Stan Berenshteyn
Stock Analyst at Wells Fargo
(1.74)
# 3,055
Out of 4,712 analysts
56
Total ratings
53.85%
Success rate
-9.18%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Stan Berenshteyn
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VEEV Veeva Systems | Maintains: Overweight | $275 → $285 | $214.86 | +32.64% | 5 | Dec 6, 2024 | |
| DOCS Doximity | Upgrades: Equal-Weight | $19 → $41 | $58.42 | -29.82% | 8 | Nov 8, 2024 | |
| OMCL Omnicell | Maintains: Equal-Weight | $30 → $41 | $44.58 | -8.03% | 11 | Oct 14, 2024 | |
| ACCD Accolade | Maintains: Equal-Weight | $7 → $6 | $3.57 | +68.07% | 10 | Oct 11, 2024 | |
| AMWL American Well | Maintains: Equal-Weight | $40 → $15 | $7.70 | +94.81% | 2 | Aug 6, 2024 | |
| HQY HealthEquity | Maintains: Overweight | $107 → $110 | $97.41 | +12.92% | 8 | Jun 20, 2024 | |
| HCAT Health Catalyst | Maintains: Overweight | $14 → $13 | $7.09 | +83.36% | 4 | May 10, 2024 | |
| GDRX GoodRx Holdings | Upgrades: Overweight | $10 | $4.52 | +121.24% | 6 | Mar 25, 2024 | |
| TDOC Teladoc Health | Maintains: Equal-Weight | $28 → $23 | $9.53 | +141.34% | 2 | Mar 6, 2023 |
Veeva Systems
Dec 6, 2024
Maintains: Overweight
Price Target: $275 → $285
Current: $214.86
Upside: +32.64%
Doximity
Nov 8, 2024
Upgrades: Equal-Weight
Price Target: $19 → $41
Current: $58.42
Upside: -29.82%
Omnicell
Oct 14, 2024
Maintains: Equal-Weight
Price Target: $30 → $41
Current: $44.58
Upside: -8.03%
Accolade
Oct 11, 2024
Maintains: Equal-Weight
Price Target: $7 → $6
Current: $3.57
Upside: +68.07%
American Well
Aug 6, 2024
Maintains: Equal-Weight
Price Target: $40 → $15
Current: $7.70
Upside: +94.81%
HealthEquity
Jun 20, 2024
Maintains: Overweight
Price Target: $107 → $110
Current: $97.41
Upside: +12.92%
Health Catalyst
May 10, 2024
Maintains: Overweight
Price Target: $14 → $13
Current: $7.09
Upside: +83.36%
GoodRx Holdings
Mar 25, 2024
Upgrades: Overweight
Price Target: $10
Current: $4.52
Upside: +121.24%
Teladoc Health
Mar 6, 2023
Maintains: Equal-Weight
Price Target: $28 → $23
Current: $9.53
Upside: +141.34%